REAL-LIFE USE OF BOTULINUM TOXIN TYPE A IN POSTSTROKE SPASTICITY: IS THERE A TIME WINDOW TO START TREATMENT?

被引：0
|
作者：
Freitas, Margarida [1 ]
Rosa, Susana [2 ]
Guimaraes, Bruno [3 ]
Martins, Joana [4 ]
Mesquita, Jose Luis [5 ]
Cardoso, Daniel [6 ]
Jacinto, Jorge [6 ]
机构：
[1] Hosp Garcia de Orta, Dept Phys & Rehabil Med, Almada, Portugal
[2] Ctr Hosp Univ Lisboa Cent CHULC, Dept Phys & Rehabil Med, Lisbon, Portugal
[3] Ctr Hosp Entre Douro & Vouga CHEDV, Dept Phys & Rehabil Med, Santa Maria Feira, Portugal
[4] Ctr Hosp & Univ Coimbra CHUC, Dept Phys & Rehabil Med, Lisbon, Portugal
[5] Ctr Hosp Univ Lisboa Norte CHULN, Dept Phys & Rehabil Med, Lisbon, Portugal
[6] Ctr Med Reabilitacao Alcoitao, Dept Adult Rehabil, Cascais, Portugal
来源：
TOXICON | 2021年 / 190卷
关键词：
AbobotulinumtoxinA; Botulinum toxin; GAS score; IncobotulinumtoxinA; OnabotulinumtoxinA; Poststroke spasticity;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of repeated botulinum toxin type A (BoNTA) in the treatment of poststroke, upper limb spasticity: a 12-month trial
    Elovic, E.
    Brashear, A.
    Kaelin, D.
    McIntosh, R.
    Liu, J.
    Turkel, C. C.
    MOVEMENT DISORDERS, 2006, 21 : S423 - S423
  • [32] Treatment with botulinum toxin type B for upper-limb spasticity
    Brashear, A
    McAfee, AL
    Kuhn, ER
    Ambrosius, WT
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2003, 84 (01): : 103 - 107
  • [33] COST-MINIMIZATION ANALYSIS OF TREATMENT OF SPASTICITY WITH BOTULINUM TOXIN TYPE A
    Tapias, G.
    Crespo, C.
    Cuesta, M.
    Forne, C.
    Garcia-Romero, M.
    Pascual-Pascual, S., I
    VALUE IN HEALTH, 2013, 16 (07) : A624 - A624
  • [34] Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients
    Sampaio, C
    Ferreira, JJ
    Pinto, AA
    Crespo, M
    Ferro, JM
    CastroCaldas, A
    CLINICAL REHABILITATION, 1997, 11 (01) : 3 - 7
  • [35] Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke
    Santamato, Andrea
    Cinone, Nicoletta
    Panza, Francesco
    Letizia, Sara
    Santoro, Luigi
    Lozupone, Madia
    Daniele, Antonio
    Picelli, Alessandro
    Baricich, Alessio
    Intiso, Domenico
    Ranieri, Maurizio
    DRUGS, 2019, 79 (02) : 143 - 160
  • [36] Determinants of discontinuation of Botulinum Toxin Type A treatment for spasticity in multiple sclerosis
    Castelli, L.
    Latino, P.
    Taborri, G.
    Prosperini, L.
    Pozzilli, C.
    Giovannelli, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 393 - 393
  • [37] Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke
    Andrea Santamato
    Nicoletta Cinone
    Francesco Panza
    Sara Letizia
    Luigi Santoro
    Madia Lozupone
    Antonio Daniele
    Alessandro Picelli
    Alessio Baricich
    Domenico Intiso
    Maurizio Ranieri
    Drugs, 2019, 79 : 143 - 160
  • [38] REAL-WORLD TREATMENT INTERVALS WITH BOTULINUM NEUROTOXIN TYPE A IN POSTSTROKE SPASTICITY MANAGEMENT-ARE DIFFERENT FORMULATIONS DIFFERENT?
    Rosa, Susana
    Guimaraes, Bruno
    Martins, Joana
    Mesquita, Jose Luis
    Freitas, Margarida
    Jacinto, Jorge
    TOXICON, 2021, 190 : S63 - S63
  • [39] Inappropriate Conclusions From the Use of Botulinum Toxin for the Treatment of Spasticity Response
    Roche, Nicolas
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (03) : 172 - 173
  • [40] Quantitative Measurement of Poststroke Spasticity and Response to Treatment With Botulinum Toxin: A 2-Patient Case Report
    Cousins, Elizabeth
    Ward, Anthony B.
    Roffe, Christine
    Rimington, Lesley D.
    Pandyan, Anand D.
    PHYSICAL THERAPY, 2009, 89 (07): : 688 - 697
12345